In August 2025, Wegovy received accelerated approval for the treatment of adults with metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver
A recent meta-analysis of Phase 3 trials reported increases in HR, based on single time point assessments, in the range of 14 bpm with both long- and short-acting GLP-1 RAs [15]
its the mental load of one more thing to do, every single day
It enrolled 2,339 adults with obesity or overweight plus at least one weight-related comorbidity, but without diabetes
If it doesnt abate, then you need to see your doctor. The FDA has updated label warnings for the diabetes drug Ozempic to include intestinal obstruction, known clinically as ileus